Author
Listed:
- Mariola Kurowska-Stolarska
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- Stefano Alivernini
(Fondazione Policlinico Universitario A. Gemelli, Catholic University of the Sacred Heart)
- Emma Garcia Melchor
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- Aziza Elmesmari
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- Barbara Tolusso
(Fondazione Policlinico Universitario A. Gemelli, Catholic University of the Sacred Heart)
- Clare Tange
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- Luca Petricca
(Fondazione Policlinico Universitario A. Gemelli, Catholic University of the Sacred Heart)
- Derek S. Gilchrist
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- Gabriele Di Sante
(Fondazione Policlinico Universitario A. Gemelli, Catholic University of the Sacred Heart)
- Chantal Keijzer
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- Lynn Stewart
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- Clara Di Mario
(Fondazione Policlinico Universitario A. Gemelli, Catholic University of the Sacred Heart)
- Vicky Morrison
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- James M. Brewer
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- Duncan Porter
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- Simon Milling
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- Ronald D. Baxter
(Institute of Infection, Immunity and Inflammation, University of Glasgow
NHS Greater Glasgow and Clyde)
- David McCarey
(NHS Greater Glasgow and Clyde)
- Elisa Gremese
(Fondazione Policlinico Universitario A. Gemelli, Catholic University of the Sacred Heart)
- Greg Lemke
(Molecular Neurobiology Laboratory, The Salk Institute for Biological Studies)
- Gianfranco Ferraccioli
(Fondazione Policlinico Universitario A. Gemelli, Catholic University of the Sacred Heart)
- Charles McSharry
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
- Iain B. McInnes
(Institute of Infection, Immunity and Inflammation, University of Glasgow)
Abstract
Current treatments for rheumatoid arthritis (RA) do not reverse underlying aberrant immune function. A genetic predisposition to RA, such as HLA-DR4 positivity, indicates that dendritic cells (DC) are of crucial importance to pathogenesis by activating auto-reactive lymphocytes. Here we show that microRNA-34a provides homoeostatic control of CD1c+ DC activation via regulation of tyrosine kinase receptor AXL, an important inhibitory DC auto-regulator. This pathway is aberrant in CD1c+ DCs from patients with RA, with upregulation of miR-34a and lower levels of AXL compared to DC from healthy donors. Production of pro-inflammatory cytokines is reduced by ex vivo gene-silencing of miR-34a. miR-34a-deficient mice are resistant to collagen-induced arthritis and interaction of DCs and T cells from these mice are reduced and do not support the development of Th17 cells in vivo. Our findings therefore show that miR-34a is an epigenetic regulator of DC function that may contribute to RA.
Suggested Citation
Mariola Kurowska-Stolarska & Stefano Alivernini & Emma Garcia Melchor & Aziza Elmesmari & Barbara Tolusso & Clare Tange & Luca Petricca & Derek S. Gilchrist & Gabriele Di Sante & Chantal Keijzer & Lyn, 2017.
"MicroRNA-34a dependent regulation of AXL controls the activation of dendritic cells in inflammatory arthritis,"
Nature Communications, Nature, vol. 8(1), pages 1-13, August.
Handle:
RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15877
DOI: 10.1038/ncomms15877
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_ncomms15877. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.